Radiation Oncology Associates
6 FOLLOWERS
Read the latest news from Radiation Oncology Associates, including studies, cancer treatment news, and more. ROA serves cancer patients in NH, ME, and MA. Founded in 1971, Radiation Oncology Associates has been serving the needs of cancer patients in New Hampshire, Maine and Massachusetts for over 45 years. One of New England's oldest and largest practices in radiation oncology, we strive..
Radiation Oncology Associates
1y ago
February 6, 2023 – Dr. Jeffrey Brower hosts a podcast discussion with the authors of the updated ASTRO Endometrial Guidelines.
To listen to the podcast and view the updated guidelines, please visit Practical Radiation Oncology.
The post Podcast: Dr. Jeffrey Brower Discusses With The Authors, The Updated ASTRO Endometrial Guidelines appeared first on Radiation Oncology Associates ..read more
Radiation Oncology Associates
1y ago
Radiation Oncology Associates would like to congratulate Andrea McKee, Brian Knab, Su Metcalfe, Thomas Sheldon, Jeffrey Brower, Jeffrey Lemons, Vivek Patel, Andy Singh, Bryan Rowe, Klaudia Hunter, William O’Meara, Matt Katz, and Asa Nixon for being selected for the distinguished honor of “Top Doctors” for 2023. This distinction is bestowed upon those doctors who have been voted by their peers as the top doctors in their given specialty, being known for providing excellent care. In addition, Jeffrey Lemons, Vivek Patel and Naomi Jiang were voted “Top Doctors Rising Stars” in Radiation Oncolog ..read more
Radiation Oncology Associates
1y ago
August 11, 2022 – Radiation Center of Greater Nashua – The First Center in Northern New England to be Awarded for their Tattoo and Mark-Free Radiation Treatment.
We are excited to announce the Radiation Center of Greater Nashua are the proud recipients of an award, recognizing our ability to offer tattoo and mark-free radiation treatments to our patients with cancer.
This award recognizes the Radiation Center of Greater Nashua as being part of an exclusive, but growing group of tattoo and mark-free centers around the world. Using a technology known as Surface Guided Radiation Therapy (SGRT ..read more
Radiation Oncology Associates
2y ago
For Dr. Kristofer Roberts, joining Radiation Oncology Associates (ROA) at Concord Hospital Payson Center for Cancer Care was part of a transcontinental journey. His career path was inspired by his mother’s own cancer experience years ago.
Dr. Roberts is from Alaska, went to college and medical school at UCLA, then completed his radiation oncology residency training at the Mayo Clinic in Minnesota in 2020 before moving farther east to Concord last August.
While he was in medical school and before he had chosen a specialty, Dr. Roberts’ mother received radiation therapy from a doctor she adore ..read more
Radiation Oncology Associates
2y ago
Radiation Oncology Associates would like to congratulate Andrea McKee, Brian Knab, Su Metcalfe, Thomas Sheldon, Jeffrey Brower, Jeffrey Lemons, Vivek Patel, Andy Singh, Bryan Rowe, Klaudia Hunter, William O’Meara, Matt Katz, and Asa Nixon for being selected for the distinguished honor of “Top Doctors” for 2022. This distinction is bestowed upon those doctors who have been voted by their peers as the top doctors in their given specialty, being known for providing excellent care. In addition, Jeffrey Lemons, Vivek Patel and Jeffrey Brower were voted “Top Doctors Rising Stars” in Radiation Onco ..read more
Radiation Oncology Associates
2y ago
From Focus, Elekta’s online magazine:
The Radiation Center of Greater Nashua (Nashua, New Hampshire), a freestanding radiation oncology center in the United States, has been awarded a four-year accreditation with the American Society for Radiation Oncology (ASTRO) Accreditation Program for Excellence (APEx®). The clinic credits Elekta software solutions for helping them make it a reality.
To learn more, read the full article on Elekt’s Focus website.
The post Radiation Center of Greater Nashua in New Hampshire awarded Accreditation Program for Excellence (APEx) appeared first on Radiat ..read more
Radiation Oncology Associates
2y ago
UF College of Medicine Alumni Jeffrey Brower, Ph.D. ’08, M.D. ’12, recently received the University of Florida’s 40 under 40 designation and an Outstanding Young Alumni award. Read a short excerpt of UF’s article below.
Established in 2006, the 40 under 40 designation and Outstanding Young Alumni awards recognize those who have made a “significant impact” within their industry and those who have made “civic or professional accomplishments at the state, national or international level.”
Jeffrey Brower earned a doctorate in molecular biology from the UF College of Medicine. As a student, he ..read more
Radiation Oncology Associates
2y ago
Radiation Oncology Associates would like to congratulate Dr. Brian Knab, Dr. Su Metcalfe, Dr. Tom Sheldon, Dr. Andrea McKee, and Dr. Asa J. Nixon for being selected for the distinguished honor of “top doctors” for 2019. This distinction is bestowed upon those doctors who have been voted by their peers as the top doctors in their given specialty, being known for providing excellent care.
Asa J. Nixon, MD, MPH Burlington, Peabody
Asa J. Nixon, MD, MPH
View Bio
Brian R. Knab, MD Londonderry, Manchester
Brian R. Knab, MD
View Bio
Andrea B. McKee, MD B ..read more
Radiation Oncology Associates
2y ago
Recently published in the Journal of Clinical Oncology, April 2019: Phase III Trial: Adjuvant Pelvic Radiation Therapy Versus Vaginal Brachytherapy Plus Paclitaxel/Carboplatin in High-Intermediate and High-Risk Early Stage Endometrial Cancer
Purpose
The primary objective was to determine if vaginal cuff brachytherapy and chemotherapy (VCB/C) increases recurrence-free survival (RFS) compared with pelvic radiation therapy (RT) in high-intermediate and high-risk early-stage endometrial carcinoma.
Patients and Methods
A randomized phase III trial was performed in eligible patients with endometr ..read more
Radiation Oncology Associates
2y ago
Recently published on PubMed, September 2019: Adjuvant Chemoradiotherapy Versus Radiotherapy Alone in Women with High-Risk Endometrial Cancer (Portec-3): Patterns of Recurrence and Post-Hoc Survival Analysis of a Randomised Phase 3 Trial
Background
The PORTEC-3 trial investigated the benefit of combined adjuvant chemotherapy and radiotherapy versus pelvic radiotherapy alone for women with high-risk endometrial cancer. We updated the analysis to investigate patterns of recurrence and did a post-hoc survival analysis.
Methods
In the multicentre randomised phase 3 PORTEC-3 trial, women with hi ..read more